#Global In-Vitro Diagnostics Industry Report

[tbrcresearchreport]

The Business Research Company offers in vitro diagnostics ivd quality control market research report 2023 with industry size, share, segments and market growth

[deshpandeisha]

Introduction to Biosensors: Principles and Applications

The global biosensors market size was USD 25.5 Billion in 2021 and is expected to register a revenue CAGR of 8.0% during the forecast period, according to latest analysis by Emergen Research. Increasing application of biosensors in agriculture and healthcare sectors and emergence of nanotechnology-based biosensors are factors projected to support market revenue growth between 2021 and 2030. In addition, rising prevalence of chronic disease such as diabetes, cardiovascular disease, and others globally and growing acceptance of biosensors by diabetics for glucose monitoring are factors contributing to revenue growth of the market. Significant advancements in biosensor technology have eased the process of blood glucose level monitoring in patients, especially in older adults, which has helped in the management of diabetes mellitus.

Other benefits of biosensors include Point of Care (POC) glucose testing and non-invasive glucose monitoring systems among others, which are expected to boost growth of the market during the forecast period. Biosensors are also being used in maternity and fertility testing, and Biosensor-based In-Vitro Diagnostic (IVD) devices are fast becoming excellent alternative tools due to the various advantages this offers. This approach offers a major advantage over conventional detection systems in medicines for an early diagnosis, enables proper screening of targeted population, and also for assessing the efficiency of a specific therapy.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/42

Competitive Terrain:

The global Biosensors industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Abbott, Medtronic, Bio-Rad Laboratories, Inc., Cytiva, LifeScan IP Holdings, LLC, Nova Biomedical, Universal Biosensors, AgaMatrix, PHC Holdings Corporation, ACON Laboratories, Inc

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Biosensors market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Biosensors market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Biosensors market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/42

Market Segmentations of the Biosensors Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Biosensors market on the basis of product, application, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019–2030)

Wearable

Non-wearable

Technology Outlook (Revenue, USD Billion; 2019–2030)

Electrochemical

Optical

Piezoelectric

Thermal

Nanomechanical

Application Outlook (Revenue, USD Billion; 2019–2030)

Healthcare

Agriculture

Bioreactor

Food Toxicity

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/biosensors-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/42

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[global-research-report]

In Vitro Diagnostics for Infectious Diseases: A Comprehensive Market Analysis

The global infectious disease in vitro diagnostics market size is expected to reach USD 28.05 billion by 2030, registering a CAGR of 2.4% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.

The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.

However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMérieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.

Infectious Disease In Vitro Diagnostics Market Report Highlights

The reagents product segment held the largest revenue share in 2023 owing to its high-volume usage in testing

The molecular diagnostics segment held the largest share in 2023 owing to an increased number of product launches in the segment and increased adoption due to its high accuracy

By application, the COVID-19 segment dominated the industry in 2023 due to the high expenditure on testing, to reduce the spread of the virus

The central laboratories segment held the highest revenue share in 2023 due to the higher accuracy of laboratory-based tests, which makes them more reliable as compared to PoC and home tests, giving these tests a competitive edge over the other two segments

North America dominated the global industry in 2023 due to its favorable regulatory framework, focus on preventive & early testing, and the higher adoption rate of novel diagnostics in this region.

Infectious Diseases In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global infectious disease in vitro diagnostics market based on products, technology, application, test location, and region:

Infectious Disease In Vitro Diagnostics (IVD) Product Outlook (Revenue, USD Billion, 2018 - 2030)

Instruments

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB And Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others Infectious Disease

Reagents

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB And Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others Infectious Disease

Software Services

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB And Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others Infectious Disease

Infectious Disease In Vitro Diagnostics (IVD) Technology Outlook (Revenue, USD Billion, 2018 - 2030)

Immunoassay

Molecular Diagnostics

Polymerase Chain Reaction (PCR)

In Situ Hybridization

Isothermal Nucleic Acid Amplification Technology (INAAT)

Chips And Microarrays

Sequencing & NGS

Transcription Mediated Amplification

Others

Microbiology

Others

Infectious Disease In Vitro Diagnostics (IVD) Application Outlook (Revenue, USD Billion, 2018 - 2030)

MRSA

Streptococcus

Clostridium Difficile

VRE

CRE

Respiratory Virus

Candida

TB And Drug-resistant TB

Gastro-intestinal Panel Testing

Chlamydia

Gonorrhea

HPV

HIV

Hepatitis C

Hepatitis B

COVID-19

Others Infectious Disease

Infectious Disease In Vitro Diagnostics (IVD) Test Location Outlook (Revenue, USD Billion, 2018 - 2030)

Point of Care

Central Laboratories

Others

Infectious Disease In Vitro Diagnostics (IVD) Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

UAE

Saudi Arabia

Kuwait

Key Players in Infectious Disease In Vitro Diagnostics (IVD) Market

QIAGEN

BD

bioMérieux SA

Hoffmann-La Roche, Ltd.

Hologic, Inc. (Gen-Probe)

Abbott

Quidel Corporation

Siemens Healthineers AG

Bio-Rad Laboratories, Inc.

Danaher

OraSure Technologies, Inc.

Order a free sample PDF of the Infectious Disease In Vitro Diagnostics (IVD) Market Intelligence Study, published by Grand View Research.

[taniyaaskd]

"Enhancing Fertility Diagnostics: Trends in the Sperm Penetration Assay Market"

"Sperm Penetration Assay Market Size And Forecast by 2032

The financial performance of these leading companies forms a crucial component of the study Sperm Penetration Assay Market. Shedding light on their profitability and sustainability. Key metrics such as revenue growth, profit margins, and investment strategies are analyzed to understand their economic strength. The report also explores strategic moves like mergers, acquisitions, and collaborations that have allowed these companies to bolster their Sperm Penetration Assay Market presence and enhance their competitive edge.

Data Bridge Market Research analyses that the sperm penetration assay market is expected to grow at a healthy CAGR during the forecast period 2022 to 2029. 

The global size of the Sperm Penetration Assay Market has witnessed remarkable expansion, supported by rising investments, technological innovations, and increasing adoption across industries. With a growing emphasis on sustainability and efficiency, the market is poised to achieve substantial growth. Insights into market share and scope highlight the dominance of leading companies and the untapped potential in emerging markets.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sperm-penetration-assay-market

Nucleus is a secure, cloud-based platform designed to streamline data transfer and management for businesses. Its intuitive interface offers practice administrators and financial managers advanced filtering options, enhancing operational efficiency.  By integrating various data sources, Nucleus enables effective prioritization of critical exposures, incorporating business context and threat intelligence to bolster security measures. Additionally, Nucleus supports seamless collaboration among multiple users across different applications, fostering rapid iteration and teamwork. Its deployment flexibility allows installation on-premises or via preferred cloud service providers, ensuring scalability and adaptability to meet diverse organizational needs.

Get More Detail: https://www.databridgemarketresearch.com/nucleus/global-sperm-penetration-assay-market 

Which are the top companies operating in the Sperm Penetration Assay Market?

The Top 10 Companies in Sperm Penetration Assay Market are key players known for their strong market presence, innovative solutions, and consistent growth. These companies often lead the market in terms of revenue, product offerings, and market share. Each contributing significantly to the development and expansion of the market. These companies are recognized for their strategic partnerships, advanced technologies, and ability to meet the changing demands of consumers and industries alike.

**Segments**

- **Type:** The market can be segmented by type into Huhner test (HT), in-vitro penetration assay (IPA), and others. The Huhner test involves mixing cervical mucus with sperm and observing their interaction under a microscope, providing valuable insights into sperm quality and function. The in-vitro penetration assay assesses the ability of sperm to penetrate into an artificial layer resembling the cervical mucus, aiding in understanding male fertility issues.

- **End-User:** The market can also be segmented by end-user into hospitals, fertility clinics, research institutes, and others. Hospitals are key end-users due to the high prevalence of infertility cases they handle. Fertility clinics rely on sperm penetration assays to diagnose fertility issues and guide treatment decisions, contributing significantly to market growth. Research institutes use these assays for scientific studies and advancements in reproductive medicine.

- **Region:** Geographically, the market can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the market due to advanced healthcare infrastructure, increasing infertility rates, and higher adoption of assisted reproductive technologies. Europe follows closely, driven by rising awareness about infertility treatments and supportive government initiatives. The Asia-Pacific region is projected to witness the fastest growth, attributed to improving healthcare facilities, changing lifestyles impacting fertility, and increasing investments in research and development.

**Market Players**

- **Hamilton Thorne, Inc.:** A prominent player in the sperm penetration assay market, Hamilton Thorne offers cutting-edge solutions for assessing sperm function and quality. Their innovative technologies help in the evaluation of male infertility and support assisted reproduction procedures.

- **Medical Electronic Systems:** With a focus on male fertility testing, Medical Electronic Systems provides advanced tools for sperm analysis and fertility assessment. Their expertise in developing precise diagnostic solutions contributes to the growth of the sperm penetration assay market.

- **Reproductive Health Science (RHS):** RHS is known for its comprehensive range of products and services related to male fertilityHamilton Thorne, Inc., Medical Electronic Systems, and Reproductive Health Science (RHS) stand out as key players in the sperm penetration assay market, each offering unique capabilities and solutions in the assessment of male fertility. Hamilton Thorne is recognized for its cutting-edge technologies that enable precise evaluation of sperm function and quality, crucial for diagnosing male infertility and supporting assisted reproduction procedures. The company's innovative offerings have cemented its position as a prominent player in the market, catering to the growing demand for advanced sperm analysis solutions.

Medical Electronic Systems specializes in male fertility testing, providing advanced tools and diagnostic solutions for comprehensive sperm analysis and fertility assessment. Their expertise in developing precise and reliable products has significantly contributed to the expansion of the sperm penetration assay market. By focusing on male fertility specifically, Medical Electronic Systems addresses a crucial aspect of reproductive health, further enhancing their market presence and relevance in the industry.

Reproductive Health Science (RHS) differentiates itself in the market through its comprehensive range of products and services related to male fertility. The company's commitment to offering holistic solutions for male reproductive health sets it apart from other market players, catering to the diverse needs of healthcare providers, fertility clinics, and research institutions. RHS's emphasis on providing new insights and advancements in male fertility contributes to shaping the future of the sperm penetration assay market, driving innovation and promoting awareness about male infertility issues.

The competitive landscape of the sperm penetration assay market is evolving, with players like Hamilton Thorne, Medical Electronic Systems, and Reproductive Health Science leading the way in technological advancements, product development, and strategic partnerships. As the demand for male fertility testing and assisted reproduction services continues to rise globally, these market players are well-positioned to capitalize on opportunities for growth and expansion. By leveraging their expertise, technological capabilities, and commitment to advancing male reproductive health, Hamilton Thorne, Medical Electronic Systems, and Reproductive Health Science are poised to shape the future of the sperm penetration assay market and drive innovation in the field of**Market Players:**

- AB Scientific Ltd. (U.S.) - Art Biotech Pvt. Ltd. (India) - Cook (U.S.) - Dxnow, Inc. (U.S.) - Eppendorf SE (U.S.) - Esco Micro Pte. Ltd. (Singapore) - Hamilton Thorne, Ltd. (U.S.) - LabIVF Asia Pte Ltd. (Singapore) - Rocket Medical plc (U.K.) - The Cooper Companies, Inc. (U.S.) - Vitrolife (Europe) - Irvine Scientific (U.S.) - Microptic (U.S.) - The Cooper Companies Inc. (U.S.)

**Market Analysis:**

The sperm penetration assay market is witnessing significant growth globally due to the increasing prevalence of infertility, advancements in assisted reproductive technologies, and rising awareness about male fertility issues. Market players such as Hamilton Thorne, Medical Electronic Systems, and Reproductive Health Science, along with the other prominent firms, are actively contributing to the expansion of the market through innovative product offerings and strategic developments. The market segmentation based on type, end-users, and region helps in targeted approaches towards addressing specific market needs and maximizing growth opportunities.

In terms of market dynamics, North America leads the global sperm penetration assay market, driven by factors such as advanced healthcare infrastructure, higher adoption rates of reproductive technologies, and increasing infertility cases. Europe closely follows North America, supported by favorable government initiatives and escalating awareness levels regarding fertility treatments. However,

Explore Further Details about This Research Sperm Penetration Assay Market Report https://www.databridgemarketresearch.com/reports/global-sperm-penetration-assay-market

Key Insights from the Global Sperm Penetration Assay Market :

Comprehensive Market Overview: The Sperm Penetration Assay Market is rapidly expanding, driven by technological advancements and changing consumer preferences.

Industry Trends and Projections: The market is expected to grow at a CAGR of X% over the next few years, with digitalization and sustainability being key trends.

Emerging Opportunities: Increasing demand for personalized and eco-friendly products presents significant growth opportunities within the market.

Focus on R&D: Companies are investing heavily in R&D to develop innovative solutions and maintain competitive advantages.

Leading Player Profiles: Leading market players continue to dominate with their strong market presence and innovation.

Market Composition: The market is characterized by a mix of large established companies and smaller, agile players contributing to competition.

Revenue Growth: The market has experienced consistent revenue growth, driven by rising consumer demand and expanding product lines.

Commercial Opportunities: There are numerous commercial opportunities in untapped regions and through technological advancements.

 Get More Reports:

Global Veterinary Equipment and Disposables Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Floor Coatings Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030 Global Thermoelectric Modules Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Wood Coating Resins Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Wiper Motor AfterMarket Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2028 Global Gas Barrier Membrane Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Solar Micro Inverter Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2028 Global Cosmetic Antioxidants Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Steel Wire Rope and Plastic Rope Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030 Global Community Acquired Pneumonia Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029 Global Bariatric Surgery Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2028 Global Kickboxing Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Data Bridge Market Research:

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975

Email:- corporatesales@databridgemarketresearch.com"

[industrynewsupdates]

A Comprehensive Overview of Life Science Tools Market Landscape

The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the ‘4D Nucleome Program’, which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Gather more insights about the market drivers, restrains and growth of the Life Science Tools Market

Life Science Tools Market Report Highlights

• By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment

• By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment

• By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market

• North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region

• Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market

Life Science Tools Market Segmentation

Grand View Research has segmented the global life science tools market on the basis of technology, product, end-use, and region:

Life Science Tools Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Genomic Technology

• Proteomics Technology

• Cell Biology Technology

• Other Analytical & Sample Preparation Technology

• Lab Supplies & Technologies

Life Science Tools Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Cell Culture Systems & 3D Cell Culture

o Instruments

o Consumables

o Cell & Tissue Culture Services

• Liquid Chromatography

o Instruments

o Consumables

o Services

• Mass Spectrometry

o Instruments

o Consumables

o Services

• Flow Cytometry

o Instruments

o Consumables

o Services

• Cloning & Genome Engineering

o Kits, Reagents, and Consumables

o Services

• Microscopy & Electron Microscopy

o Instruments

o Consumables

o Services

• Next Generation Sequencing

o Instruments

o Consumables

o Services

• PCR & qPCR

o Instruments

o Consumables

o Services

• Nucleic Acid Preparation

o Instruments

o Consumables

o Services

• Nucleic Acid Microarray

o Instruments

o Consumables

o Services

• Sanger Sequencing

o Instruments

o Consumables

o Services

• Transfection Devices & Gene Delivery Technologies

o Equipment

o Reagents

• NMR

o Instruments

o Consumables

o Services

• Other Separation Technologies

o Instruments

o Consumables

o Services

• Other Products & Services

o Antibodies

o General Supplies

o Others

Life Science Tools End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Government & Academic

• Biopharmaceutical Company

• Healthcare

• Industrial Applications

• Others

Life Science Tools Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

o Switzerland

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

o Singapore

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Life Science Tools Market Intelligence Study, published by Grand View Research.

[amruta1]

In Vitro Diagnostics Market  Trends and Forecast Analysis: Unlocking Opportunities and Predicting Industry Growth through 2032

Polaris Market Research recently released a comprehensive report titled In Vitro Diagnostics Market Trend. The research report provides valuable insights and data, covering global In Vitro Diagnostics market value, competitor market share, and regional market shares. In addition, it sheds light on current market trends, future opportunities, and essential information stakeholders need to know to navigate the dynamic landscape of the market successfully.

The research report is aimed at providing readers with an in-depth examination of the market, unveiling expert opinions, key facts and figures, and recent developments across the globe. It also includes an all-inclusive perspective on technological advancements and other important shifts. By going through the research study, stakeholders can make informed decisions to stay ahead of the curve.

Global In Vitro Diagnostics Market size and share is currently valued at USD 80.02 billion in 2024 and is anticipated to generate an estimated revenue of USD 152.62 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

Market Dynamics:

The research report examines all the key forces affecting the performance and behavior of the In Vitro Diagnostics market. These include:

Supply and Demand Fluctuations: The research report analyzes all the key factors that can cause supply and demand fluctuations in the market. Also, it examines other factors, such as product hoarding and changes in income, that can affect the demand and supply for specific products or services.

Technological Advancements: The study analyzes the development of new technologies and their impact on improving efficiency, productivity, and convenience. Besides, other innovations that can have a favorable impact on the market demand have been covered in the study.

Regulatory Changes: The research report sheds light on regulatory changes and their impact on the In Vitro Diagnostics market expansion. It also covers the implementation of favorable initiatives and policies that support market development.

Browse Full Insights:

Competitive Landscape:

The research report includes a thorough assessment of the current state of competition in the market. It examines all the major In Vitro Diagnostics market key players, covering several aspects such as company introduction, product/service offerings, revenue generated, and operating regions. By going through the research report, stakeholders can better understand the options available to their target customers. Also, it can assist businesses in better understanding their current market position and developing strategies to improve it.

A few of the key players covered in the market research report are:

Abbott

Agilent Technologies, Inc.

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories, Inc.

Charles River Laboratories

Danaher Corporation

F. Hoffmann-La Roche Ltd.

Qiagen

Quest Diagnostics Incorporated

QuidelOrtho Corporation

Siemens Healthineers AG

Sysmex Corporation

Thermo Fisher Scientific, Inc.

Segmental Analysis:

The research report divides the market into various groups and sub-groups that share similar characteristics. Segmental analysis helps businesses devise effective and more relevant marketing strategies by tailoring them to specific segments. Also, stakeholders can better articulate customer needs and offer products and services that cater to them. Besides, stakeholders can evaluate and prioritize top segments in the market.

Regional Overview:

The research report provides comprehensive information about the regional In Vitro Diagnostics market distribution. It covers the major market trends and market opportunities in all the leading regions. Also, it provides a thorough market assessment at the global, national, and regional levels. Other key metrics covered in the study are production capacity, pricing strategy, supply and demand ratios, and growth rates.

The geographic analysis covers the following regions and sub-regions in the market:

• North America (US, Canada) • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, and Rest of Europe) • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, and Rest of Asia Pacific) • Latin America (Brazil, Mexico, Argentina, and Rest of Latin America) • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)

Research Methodology:

The report uses industry-standard methodologies to provide an accurate and reliable In Vitro Diagnostics market analysis. It makes use of both primary and secondary research techniques to offer extensive information about the market. All the assumptions, findings, and estimations in the research report are validated with accurate information from experts in the industry. Market breakup procedures have been used in the study to provide an accurate estimation of all the key regions and segments.

Reasons to Buy Report:

• The research study provides a thorough analysis of all the key trends that are anticipated to drive market growth. • An estimation of the demand for different types of services/products in the market has been provided in the report. • Sheds light on the major strategic developments and their impact on market development in the upcoming years. • Includes reliable projections of the In Vitro Diagnostics market considering production value and overall capacity. • Provides an assessment of the marketing channels and entry strategies for new entrants and established players.

More Trending Latest Reports By Polaris Market Research:

Home Solar System Market

Small Gas Engines Market

Pre-engineered Building Market

Polyurethane Market

Broadcast Equipment Market

Soil Monitoring Market

Cardiac Marker Testing Market

Automotive Operating System Market

[lovelypol]

Medical Device Testing Outsourcing: $3.5B in 2023 to $7.2B by 2033 (7.5% CAGR)

Medical Device Analytical Testing Outsourcing Market offers specialized services provided by third-party organizations to rigorously test and analyze medical devices. These services ensure compliance with regulatory standards, enhance product safety and efficacy, and support manufacturers in accelerating time-to-market while reducing operational costs.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS25883 &utm_source=SnehaPatil&utm_medium=Article

Key Market Drivers

The market is experiencing robust growth, driven by:

Increasing Regulatory Scrutiny: Rising emphasis on product safety and efficacy has amplified the need for comprehensive testing.

Cost-Efficiency: Outsourcing helps manufacturers optimize resources and focus on core competencies.

Technological Advancements: The growing complexity of medical devices necessitates specialized and advanced testing capabilities.

Market Insights

The chemical characterization segment leads the market, accounting for 38% of the share in 2023, driven by stringent safety standards and the necessity for thorough material analysis.

Microbiology and sterility testing follow closely with a 32% share, underscoring the importance of ensuring device sterility and patient safety.

Biocompatibility testing holds a 30% share, reflecting the demand for evaluating device compatibility with biological systems.

In 2023, the global market recorded approximately 1.2 billion tests conducted, showcasing the growing reliance on outsourced testing services.

Regional Highlights

North America dominates the market due to advanced healthcare infrastructure and the high concentration of medical device manufacturers.

Europe follows, supported by a robust regulatory framework and a rising demand for innovative medical technologies.

The United States and Germany stand out as leading contributors, reflecting significant demand for outsourced testing services in these regions.

Market Segmentation

By Type: Chemical Testing, Physical Testing, Microbiological Testing, Biocompatibility Testing, Stability Testing, Electromagnetic Compatibility Testing, Packaging Testing By Product: Instruments, Reagents, Consumables By Services: Method Development, Method Validation, Extractables and Leachables Testing, Material Characterization, Batch Release Testing, Product Life Cycle Testing By Technology: Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Flow Cytometry, Mass Spectrometry, Electrophoresis, Microscopy By Component: Sensors, Transducers, Microfluidics By Application: Cardiology Devices, Orthopedic Devices, In Vitro Diagnostic Devices, Ophthalmic Devices, Dental Devices, Drug Delivery Devices By Device: Wearable Devices, Portable Devices, Stationary Devices By Process: Preclinical Testing, Clinical Testing, Post-Market Surveillance By End User: Medical Device Manufacturers, Research Laboratories, Academic Institutions

Leading Market Players

Key players such as Eurofins Scientific, SGS SA, and Charles River Laboratories drive the market with their advanced technologies and robust testing capabilities, maintaining a competitive edge in this dynamic industry.

#MedicalDevices #AnalyticalTesting #OutsourcingServices #MedicalInnovation #HealthcareSafety #RegulatoryCompliance #BiocompatibilityTesting #ChemicalCharacterization #SterilityTesting #AdvancedTechnologies #GlobalHealthcare #PatientSafety #DeviceTesting #ResearchAndDevelopment #QualityAssurance

The Medical Device Analytical Testing Outsourcing Market is set to expand further as advancements in medical device technologies and stringent regulatory requirements fuel the demand for precise, specialized testing services.

[marketprofessional]

Tissue Diagnostics Market Size, Share & Growth by 2033

Tissue Diagnostics Market Overview The Global Tissue Diagnostics Market has seen continuous development in the past couple of years and is anticipated to grow much further during the forecast period. The exploration introduces a total evaluation of the Tissue Diagnostics Market and contains Future patterns, Current Growth Factors, mindful sentiments, certainties, chronicled information, and factually bolstered and industry-approved market information.

According to Straits Research, the global Tissue Diagnostics market size was valued at USD 5185.23 Million in 2022. It is projected to reach from USD XX Million in 2023 to USD 9375.02 Million by 2031, growing at a CAGR of 6.8% during the forecast period (2023–2031).

After identifying promising candidates, they undergo extensive testing and optimization to enhance their effectiveness, safety, and pharmacokinetic properties. This entire process of Tissue Diagnostics Market may take several years and necessitates collaboration between scientists from diverse fields such as chemistry, biology, and pharmacology. Irrespective of the challenges encountered during Tissue Diagnostics Market, it has the potential to revolutionize lives by providing new treatments for various diseases.

Request Sample Report of Global Tissue Diagnostics Market @ https://straitsresearch.com/report/tissue-diagnostics-market/request-sample

Competitive Analysis The report contains an in-depth analysis of the vendor’s profile, including financial health, business units, key business priorities, SWOT, strategies, and views.

Abbott Laboratories F. Hoffmann-La Roche Ltd Siemens Healthineers bioMerieux Bio SB DiaGenic Enzo Life Sciences, Inc Vitro Sa (Master Diagnóstica) Tissuegnostics Gmbh Abcam Plc Sakura Finetek Japan Co., Ltd Cell Signaling Technology, Inc The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant R&D investments.

Request Sample Report of Global Tissue Diagnostics Market @ https://straitsresearch.com/report/tissue-diagnostics-market/request-sample

Vendors across different verticals are planning for high investments in this market, and as a result, the market is expected to grow at an impressive rate in the upcoming years. The key players are adopting various organic and inorganic growth strategies such as mergers & acquisitions, collaboration & partnerships, joint ventures, and a few other strategies to be in a strong position in the global market.

Market Segmentation Analysis The report provides a wide-ranging evaluation of the market, providing in-depth qualitative insights, historical data, and supportable projections along with the assumptions about the Tissue Diagnostics Market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendor’s portfolio, blogs, white papers, and vendor presentations. Thus, the research report represents every side of the Tissue Diagnostics Market and is segmented on the basis of regional markets, offerings, applications, and end-users.

By Technology IHC {Instruments [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other products], Consumables [Reagents, Antibodies, Kits]} In-Situ Hybridization {Instruments, Consumables, Software} Primary and Special Staining Digital Pathology and Workflow {Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage and Communication} Anatomic Pathology {Instruments [Microtomes and Cryostat microtomes, Tissue processors, Automatic strainers, Other products], Consumables [Reagents and Antibodies, Probes and Kits, Others]} By Applications Breast Cancer Prostate Cancer Gastric Cancer Non-Small Cell Lung Cancer Other Cancers By End-User Hospitals Research Laboratories Pharmaceutical Organizations Contract Research Organizations (CROs) Access Detailed Segmentation @ https://straitsresearch.com/report/tissue-diagnostics-market/segmentation

Regional Analysis for Tissue Diagnostics Market The regional analysis offers a comprehensive view of the Tissue Diagnostics Market sales and growth across global and country-level markets. It provides volume and market size data by region, with insights into growth trends in countries like the United States, Canada, Germany, France, China, Japan, and more. The analysis also covers major regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Benefits Tissue Diagnostics Market Industry companies to ensure business continuity with powerful protection by constantly checking the report and representing attractive growth opportunities for the companies. Tissue Diagnostics Market handles all the needs of the operators by allowing them to improve their services and concentrate on their core business. Tissue Diagnostics Market Research aims to increase business agility and reduce operational and capital expenditure with improved technology rollouts and capacity planning. The report discusses service types and regions related to this Tissue Diagnostics Market. Further, the report provides details about the major challenges affecting the market growth.

Buy Now: https://straitsresearch.com/buy-now/tissue-diagnostics-market

Other Features of the Report: Provides a thorough analysis of the key strategies with a focus on the corporate structure, R&D methods, localization strategies, production capabilities, sales, and performance in various companies. Provides valuable insights into the product portfolio, including product planning, development, and positioning. Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

About Us: By Technology IHC {Instruments [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other products], Consumables [Reagents, Antibodies, Kits]} In-Situ Hybridization {Instruments, Consumables, Software} Primary and Special Staining Digital Pathology and Workflow {Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage and Communication} Anatomic Pathology {Instruments [Microtomes and Cryostat microtomes, Tissue processors, Automatic strainers, Other products], Consumables [Reagents and Antibodies, Probes and Kits, Others]} By Applications Breast Cancer Prostate Cancer Gastric Cancer Non-Small Cell Lung Cancer Other Cancers By End-User Hospitals Research Laboratories Pharmaceutical Organizations Contract Research Organizations (CROs) > StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: Email: sales@straitsresearch.com Website: https://straitsresearch.com/

[researchreportinsight]

In Vitro Diagnostics (IVD) Industry Growth Analysis & Forecast Research Report, 2030

The global in vitro diagnostics (IVD) market reached an estimated size of USD 77.92 billion in 2023, with expectations for a compound annual growth rate (CAGR) of 4.4% from 2024 to 2030. This market growth is primarily driven by the increasing use of IVD tools due to rising cases of infectious and chronic diseases worldwide. Automated IVD systems are becoming more common in hospitals and laboratories, as they provide accurate, fast, and error-free diagnoses, helping meet the growing demand for efficient healthcare services. Additionally, IVD market expansion is fueled by frequent product launches from key industry players. For example, in November 2023, ARUP Laboratories received a CE mark from the EU-IVDR for AAV5 DetectCDx, a companion diagnostic that helps identify eligibility for severe hemophilia Some patients to receive BioMarin’s gene therapy, Roctavian.

Major companies in the IVD market are employing various strategies to strengthen their position and bring more advanced and diverse products to their customers. New product launches and partnerships are among the most common tactics. For instance, in March 2023, BD received FDA 510(k) clearance for the BD Vaginal Panel on its BD COR System, a tool designed to detect infectious causes of vaginitis. In another instance, in August 2023, the Precision Medicine Centre (PMC) partnered with the Regional Molecular Diagnostic Service (RMDS) to implement genomic technology for cancer diagnosis in Northern Ireland. These partnerships and product developments highlight how key players are focused on expanding their diagnostic offerings to meet growing healthcare needs.

Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics (IVD) Market

Supportive initiatives from government and non-governmental bodies are also contributing to the market's growth by enhancing access to essential diagnostic tools. In October 2023, the World Health Organization (WHO) released an updated Essential Diagnostics List (EDL), a comprehensive catalog of vital IVD products that aids countries in making informed decisions on diagnostic tools. This list provides evidence-based recommendations, ensuring that essential diagnostic products are accessible to the people who need them most. Additionally, in August 2023, the Africa CDC collaborated with the Africa Development Agency-New Partnership for Africa's Development (AUDA-NEPAD) to improve access to diagnostic tests across the African continent. Such initiatives are expected to further support the expansion of the IVD market, especially in regions with limited healthcare resources.

The global aging population, coupled with growing awareness of early disease detection, has led to an increase in routine check-ups. This trend is particularly relevant because the majority of deaths due to infections and chronic conditions occur in people over 75. According to the UK's Office for Budget Responsibility, healthcare costs have seen a significant rise, which can place economic strain on countries with rapidly aging populations. However, these increased expenditures are likely to boost the IVD market, as diagnostic testing becomes essential in managing the healthcare needs of older adults.

End-use Segmentation Insights:

Hospitals represented the largest revenue share in the IVD market in 2023, largely due to an increase in hospital admissions requiring rapid diagnostic support. The continuous development of healthcare infrastructure, supported by government initiatives, is further improving hospital facilities, thereby increasing demand for hospital-based IVD testing. IVD tests are frequently purchased by hospitals and are utilized in large volumes due to their critical role in providing fast, accurate results for patient care. In the U.S. alone, there are over 6,129 hospitals, all of which rely on IVD tests for essential decision-making in patient care.

In December 2023, the American Hospital Association advocated to the FDA that regulatory requirements for devices should not apply to hospitals' laboratory-developed tests (LDTs), which could allow hospitals greater flexibility in their use of in-house diagnostic tools. Meanwhile, the homecare segment is anticipated to see high growth from 2024 to 2030, driven by the aging population and increasing demand for at-home diagnostic devices. There is a particular need for novel molecular diagnostic and immunoassay platforms that enable patients to perform self-tests conveniently at home. For example, in February 2023, the FDA granted Emergency Use Authorization (EUA) to the first over-the-counter (OTC) home diagnostic test capable of distinguishing between influenza A, influenza B, and SARS-CoV-2 (the virus causing COVID-19). This authorization demonstrates the shift towards providing individuals with more autonomy in managing their health through accessible at-home testing solutions.

Order a free sample PDF of the In Vitro Diagnostics (IVD) Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

In Vitro Diagnostics (IVD) Industry In-depth Analysis and Forecast Report, 2030

The global in vitro diagnostics (IVD) market reached an estimated size of USD 77.92 billion in 2023, with expectations for a compound annual growth rate (CAGR) of 4.4% from 2024 to 2030. This market growth is primarily driven by the increasing use of IVD tools due to rising cases of infectious and chronic diseases worldwide. Automated IVD systems are becoming more common in hospitals and…

[global-research-report]

Global Demand for Recombinant Proteins: Market Analysis and Forecast

The global recombinant proteins market size is expected to reach USD 5.58 billion in 2030 and is projected to grow at a CAGR of 10.2% from 2025 to 2030. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cancer cases and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19. Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The main drivers of the global industry are the rise in pharmaceutical firms’ R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights

The cytokines & growth factors segment held the largest share of 24.6% of the market in 2024. This segment is anticipated to grow exponentially throughout the forecast period.

The therapeutics segment dominated the global market with a share of 34.2% in 2024 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases.

The pharma & biotechnology companies segment captured the largest market share of 38.1% in 2024. The inclination towards biologics and biosimilars has resulted in a cascade of multi-million investments by bio-manufacturers in R&D to grow the pipeline of products, devise new technologies, and advance bioprocessing tools.

The mammalian segment held the largest revenue share of 42.1% of the recombinant proteins market in 2024.

North America was the dominant region in 2024 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, the presence of key players, and a rise in healthcare spending in the region.

Recombinant Proteins Market Segmentation

Grand View Research has segmented the global recombinant proteins market based on product, application, end use, host cell, and region:

Recombinant Proteins Product Outlook (Revenue, USD Million, 2018 - 2030)

Cytokines & Growth Factors

Interferons (IFNs)

Interleukins (ILs)

Others

Antibodies

Immune checkpoint proteins

Virus Antigens

Enzymes

Kinases

Metabolic enzymes

Others

Recombinant Regulatory Protein

Hormones

Others

Recombinant Proteins Application Outlook (Revenue, USD Million, 2018 - 2030)

Drug Discovery & Development

Therapeutics

Biologics

Vaccines

Cell & Gene Therapies

Others

Research

Others

Recombinant Proteins End Use Outlook (Revenue, USD Million, 2018 - 2030)

Pharma & Biotechnology Companies

Academic & Research Institutes

Diagnostic Laboratories

Others

Recombinant Proteins Host Cell Outlook (Revenue, USD Million, 2018 - 2030)

Mammalian systems

Insect Cells

Yeast & Fungi

Bacterial Cells

Others

Recombinant Proteins Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players

Sino Biological, Inc.

Bio-Techne

GenScript

Bio-Rad Laboratories, Inc.

Merck KGaA

Thermo Fisher Scientific

Proteintech Group, Inc.

Enzo Life Sciences, Inc. 

Abnova Corporation

RayBiotech Life Inc.

STEMCELL Technologies Inc.

Order a free sample PDF of the Recombinant Proteins Market Intelligence Study, published by Grand View Research.

[harshnews]

Reporter Gene Assay Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook

"Reporter Gene Assay Market – Industry Trends and Forecast to 2029

Global Reporter Gene Assay Market, By Product (Assay Kits and Reagents), Application (Promoter Structural and Functional Analysis, Cell Signaling Pathways, Protein Interaction, In Vitro Studies, Clinical and Gene Regulation), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, CROs) – Industry Trends and Forecast to 2029.

Access Full 350 Pages PDF Report @

**Segments**

- **By Product Type**: The reporter gene assay market can be segmented by product type into assay kits, reagents, cell lines, and instruments. Assay kits are essential in reporter gene assays as they contain all the necessary components for the analysis. Reagents are crucial for the preparation and execution of the assays, providing the necessary chemicals and substrates. Cell lines are another key segment as they play a vital role in gene expression studies. Instruments segment includes luminometers, microplate readers, and other equipment required for detection and analysis.

- **By Application**: The market for reporter gene assays can be segmented by application into drug discovery and development, gene regulation studies, protein-protein interaction, and promoter analysis. Drug discovery and development is a significant application segment as reporter gene assays are widely used in screening compounds and evaluating their effects. Gene regulation studies involve the analysis of gene expression, transcription, and translation processes. Protein-protein interaction studies utilize reporter gene assays to investigate how proteins interact within cells. Promoter analysis segment focuses on the study of gene promoters and their regulation.

- **By End User**: End users of reporter gene assays include pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and others. Pharmaceutical and biotechnology companies are the primary users of reporter gene assays, employing them in various stages of drug discovery and development. Academic and research institutes utilize these assays for fundamental research and studies. CROs offer assay services to pharma companies and research institutions, driving the usage of reporter gene assays in outsourced projects.

**Market Players**

- **Promega Corporation**: Promega Corporation is a prominent player in the reporter gene assay market, offering a wide range of assay kits, reagents, and instruments. The company is known for its high-quality products and innovative solutions in gene expression analysis.

- **Thermo Fisher Scientific, Inc.**: Thermo Fisher Scientific is a leading provider of reporter gene assay products, including cell lines, rePromega Corporation and Thermo Fisher Scientific, Inc. are key market players in the reporter gene assay market, each contributing significantly to the growth and development of this sector. Promega Corporation is renowned for its extensive range of assay kits, reagents, and instruments tailored for gene expression analysis. The company's commitment to delivering high-quality products and innovative solutions has solidified its position in the market. Its diverse product portfolio caters to the varying needs of researchers and pharmaceutical companies engaged in drug discovery and development and gene regulation studies. Promega Corporation's emphasis on technological advancements and customer-centric approach further enhances its competitive edge in the reporter gene assay market.

Thermo Fisher Scientific, Inc. stands out as a leading provider of reporter gene assay products, including cell lines, reagents, and instruments that are essential for conducting accurate and reliable gene expression analyses. The company's comprehensive offerings in this segment cater to a broad spectrum of applications, including drug discovery, gene regulation studies, and protein-protein interaction analysis. Thermo Fisher Scientific's focus on research and development has resulted in the introduction of cutting-edge solutions that enable researchers to gain deeper insights into gene expression dynamics. The company's commitment to innovation, coupled with its strong market presence and global distribution network, positions it as a key player driving the growth of the reporter gene assay market.

In terms of market dynamics, the reporter gene assay market is experiencing steady growth driven by the increasing demand for advanced tools and technologies for gene expression analysis. The rise in research activities in areas such as drug discovery, gene regulation, and protein-protein interaction studies further fuels the adoption of reporter gene assays across different end-user segments. Pharmaceutical and biotechnology companies remain the primary users of reporter gene assays, leveraging these tools to streamline their drug development pipelines and enhance target identification and validation processes. Academic and research institutes also play a crucial role in driving market growth, as they rely on reporter gene assays for fundamental research and elucidating gene regulatory mechanisms.

The emergence of contract research organizations (C**Global Reporter Gene Assay Market, By Product (Assay Kits and Reagents), Application (Promoter Structural and Functional Analysis, Cell Signaling Pathways, Protein Interaction, In Vitro Studies, Clinical and Gene Regulation), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, CROs) – Industry Trends and Forecast to 2029.**

The global reporter gene assay market is witnessing significant growth attributed to the escalating demand for advanced tools for gene expression analysis. The market segmentation based on product type includes assay kits, reagents, cell lines, and instruments. Assay kits play a crucial role in facilitating the analysis by providing all necessary components, while reagents are essential for the execution of assays. Cell lines are pivotal for gene expression studies, and instruments such as luminometers and microplate readers are required for detection and analysis purposes. In terms of applications, the market can be segmented into drug discovery and development, gene regulation studies, protein-protein interaction, and promoter analysis. Drug discovery is a key application for reporter gene assays, aiding in compound screening and evaluation. Gene regulation studies involve the analysis of gene expression mechanisms, while protein-protein interaction studies focus on understanding cellular protein interactions. The promoter analysis segment is dedicated to studying gene promoters and their regulation.

End users of reporter gene assays encompass pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Reporter Gene Assay Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Reporter Gene Assay Market.

Global Reporter Gene Assay Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The following are the regions covered in this report.

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

The Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]

This study answers to the below key questions:

What are the key factors driving the Reporter Gene Assay Market?

What are the challenges to market growth?

Who are the key players in the Reporter Gene Assay Market?

What are the market opportunities and threats faced by the key players?

Browse Trending Reports:

Air Sports Equipment Market Secondary Macronutrients Market Blood Gas Analyzer Market Methotrexate Injection Market Smart Room Heater Market Battery Market Infrastructure As a Service Iaas Health Cloud Market Peritonitis Treatment Market Yacht Charter Market Next Generation Printing Ink Market Functional Confectionery Market Herbal Ready To Brink Beverages Market Wirewound Resistor Market Gelatin Substitutes Market Soy Based Surfactants Market Trimethlyaminuria Market Secondary Agricultural Nutrients Market Tomatoes Market Electric Kick Scooters Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[healthcaremarketanalysis]

Allergy Diagnostics Industry worth $9.8 billion by 2029, with a CAGR of 11.0%

Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Download PDF Brochure

Browse in-depth TOC on “Allergy Diagnostics Market”

248 — Tables

57 — Figures

307 — Pages

The consumables segment is expected to account for the largest share in 2023.

The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience significant growth over the projected period. The increasing demand for rapid diagnosis of allergic patients which is driven by increasing number of allergic cases can be attributed for the larger share of this segment during the forecast period.

In Vivo test segment held the largest market share in the Allergy Diagnostics market.

Based on the test type, the Allergy Diagnostics market is segmented into in vivo tests and in vitro tests. In 2023, the in vivo tests segment accounted for the largest share of the Allergy Diagnostics market. The growth of this segment is mainly driven by the growing adoption of various in vivo tests, such as skin prick tests which is considered as the first line of diagnosis for allergy and favorable government support and guidelines.

Inhaled allergy segment held the largest market share in the Allergy Diagnostics market.

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2023, the inhaled allergens segment accounted for the largest share of the Allergy Diagnostics market due to the rising environmental pollution, rising home dust & mites coupled with other factors such as pollen, fungus, mold, and dust, and switching lifestyles, including rise in indoor activities and exposure to indoor allergen.

North America dominates the global Allergy Diagnostics market

Based on the region, the Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market is driven by availability of technologically advanced products and growing research on allergy by companies and government. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, lifestyle changes and climatic conditions, increased ozone and industrial pollution levels, and the rising demand for quality medical care are some of the major factors driving the growth of this regional market.

Request Sample Pages

Allergy Diagnostics Market Dynamics:

Drivers:

1. High incidence and heavy economic burden of allergic diseases

Restraints:

1. High pricing of allergy diagnostic instruments

Opportunities:

1. Integration of AI in allergy diagnosis

Challenge:

1. Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

· By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)

· By Designation: C-level (30%), Director-level (20%), and Others (50%)

· By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report:

Recent Developments of Allergy Diagnostics Industry:

· In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, “Minaris Medical”). After this share acquisition is finished, Minaris Medical — which runs companies that deal with automated analytical tools and in vitro diagnostic reagents — will be consolidated under Canon Medical.

· In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.

· In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Allergy Diagnostics Market — Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Allergy Diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

· Analysis of key drivers (global rise in prevalence and heavy economic burden of allergic illnesses, growing environmental pollution, and insurance coverage), restraints (high costs of analyzers and access is limited to healthcare services), opportunities (use of mHealth and integration of AI in allergy diagnosis), and challenges (a few number of allergists and challenges during diagnosis of allergy) influencing the growth of the Allergy Diagnostics market

· Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Allergy Diagnostics market.

· Market Development: Comprehensive information about lucrative markets — the report analyses the Allergy Diagnostics market across varied regions.

· Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Allergy Diagnostics market

· Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], among others in the Allergy Diagnostics market strategies.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1–888–600–6441

UK +44–800–368–9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

Content Source:

[healthcare-skyquest]

In Vitro Diagnostics Market: Revolutionizing Medical Testing

The In Vitro Diagnostics (IVD) Market is at the forefront of medical diagnostics, enabling healthcare providers to detect diseases and conditions through tests performed outside the body. As demand for early detection and accurate diagnostic tools increases, the IVD market is witnessing rapid growth. This article delves into the market segmentation, key growth drivers, and leading companies shaping the industry, providing valuable insights for decision-makers.

Market Overview

According to SkyQuest’s In Vitro Diagnostics Market report, the global IVD market is valued at USD 87.93 Billion in 2023 and is projected to grow at a CAGR of 5.3%. The market’s expansion is driven by the rising prevalence of chronic diseases, the growing importance of early disease detection, and technological advancements in diagnostics.

Request Your Free Sample: - https://www.skyquestt.com/sample-request/in-vitro-diagnostics-market

Market Segmentation

By Product Type:

Reagents & Kits: Essential for a wide variety of diagnostic tests, including immunoassays and molecular diagnostics.

Instruments: Diagnostic tools such as analyzers and automated systems used in laboratories and healthcare settings.

Software & Services: Used for managing data, improving accuracy, and ensuring compliance with regulatory standards.

By Application:

Infectious Diseases: A leading segment, especially with the demand for COVID-19 diagnostics.

Cancer: Rising incidence of cancer has fueled the need for accurate diagnostic tools.

Cardiology: IVD tools for cardiovascular diseases are seeing growing demand due to an increasing global burden.

Diabetes: Blood glucose monitoring systems dominate this segment, with widespread use among diabetic patients.

Autoimmune Diseases: IVD tests play a crucial role in diagnosing autoimmune disorders.

By End-User:

Hospitals & Clinics: Major users of IVD tools, especially for infectious diseases and chronic conditions.

Diagnostic Laboratories: Central hubs for conducting a wide range of tests with high accuracy and reliability.

Research & Academic Institutions: Key in driving innovation and new test development.

Homecare Settings: Growing segment with the rise in at-home diagnostic tools, particularly for chronic conditions.

Take Action Now: Secure Your Report Today - https://www.skyquestt.com/buy-now/in-vitro-diagnostics-market

Key Growth Drivers

Increasing Prevalence of Chronic Diseases: Rising cases of cancer, diabetes, and cardiovascular diseases are driving the demand for IVD tests.

Technological Innovations: Advancements in molecular diagnostics, AI-driven analysis, and automation are enhancing the efficiency and accuracy of diagnostic tools.

Demand for Personalized Medicine: IVD plays a pivotal role in tailoring treatments to individual patients, fueling market growth.

Aging Population: As the global population ages, the demand for diagnostic tests for age-related diseases like Alzheimer’s and cardiovascular conditions is on the rise.

Leading Companies in the Market

SkyQuest’s In Vitro Diagnostics Market report highlights the following key players in the industry:

Roche Diagnostics

Abbott Laboratories

Thermo Fisher Scientific Inc.

Danaher Corporation

Siemens Healthineers

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

bioMérieux SA

Qiagen N.V.

Sysmex Corporation

Read More at: - https://www.skyquestt.com/report/in-vitro-diagnostics-market

Challenges and Opportunities

While regulatory hurdles and high costs of advanced diagnostic tools remain challenges, the IVD market offers numerous opportunities. The increasing focus on point-of-care testing and the integration of AI in diagnostics present significant growth avenues for industry players.

Future Outlook

The In Vitro Diagnostics Market is set to experience robust growth as healthcare shifts towards early detection and preventive care. Companies that invest in cutting-edge technologies and innovative diagnostic solutions will be well-positioned to lead in this evolving market.

The In Vitro Diagnostics Market is transforming the healthcare landscape, offering essential tools for early diagnosis and effective treatment planning. Decision-makers who stay ahead of trends and leverage technological advancements will thrive in this rapidly growing industry. For more detailed insights, explore SkyQuest’s In Vitro Diagnostics Market report.

[marketanalysisdata]

In Vitro Diagnostics Industry Research Report 2030 By Players, Regions, Types & Applications

The global in vitro diagnostics (IVD) market, valued at an estimated USD 80.71 billion in 2024, is anticipated to grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2030. This projected growth is largely driven by the increasing utilization of IVD tools and technologies, a response to the rising incidence of both infectious and chronic diseases globally. The development and implementation of automated IVD systems in laboratories and hospitals further contribute to this expansion, offering healthcare providers tools to make diagnoses that are efficient, precise, and free from errors. Additionally, the continual launch of new IVD products by leading companies plays a significant role in fueling this market’s growth.

A noteworthy example of this innovation in IVD products is seen in ELITechGroup’s recent expansion of its diagnostic portfolio. In January 2024, ELITechGroup introduced the GI Bacterial PLUS ELITe MGB Kit, which received CE-IVDR certification. This product marks the beginning of the company’s Gastrointestinal (GI) assay panel and is designed to detect bacterial pathogens responsible for GI infections. ELITechGroup’s expansion plans include three more kits for launch within the next quarter, covering a broader spectrum of gastrointestinal infections. These new products aim to equip laboratories and healthcare professionals with advanced tools for precise diagnosis and improved management of GI conditions.

Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics Market

Regional Insights:

North America In Vitro Diagnostics Market:

The North American in vitro diagnostics (IVD) market led the global sector in 2024, holding a 42.28% share. The region is expected to maintain its dominance throughout the forecast period, largely driven by several key factors, including the growing prevalence of chronic diseases, the presence of established IVD companies, the frequent introduction of innovative diagnostic tests, and strong government funding support. For example, in January 2023, BD and CerTest Biotec obtained an Emergency Use Authorization (EUA) from the U.S. FDA for a PCR test to detect the Mpox virus, highlighting regulatory support for advanced diagnostics. The increasing demand for genetic testing, particularly for personalized treatments in diabetes and cancer, is further expected to support the growth of the IVD market in North America.

Europe In Vitro Diagnostics Market Trends:

The European IVD market is growing, driven by an emphasis on infectious disease testing, molecular diagnostics, and adherence to regulatory requirements like CE-IVDR. Following the COVID-19 pandemic, demand for infectious disease diagnostics surged, with companies like Siemens Healthineers introducing platforms such as the Atellica CI Analyzer for efficient testing. The molecular diagnostics sector is also expanding, with ELITechGroup’s CE-IVDR-certified GI Bacterial PLUS kit as a recent example, aimed at detecting gastrointestinal infections. Stringent IVDR standards in Europe foster innovation, improving diagnostic accuracy and safety across the continent.

Asia Pacific In Vitro Diagnostics Market Trends:

The Asia Pacific IVD market is projected to experience significant growth, with a CAGR of 8.59% over the forecast period. Key drivers include stabilizing economies, a rapidly growing middle class, supportive government policies, and rapid urbanization. For instance, in October 2023, Fapon partnered with Halodoc to boost IVD product sales and services in Indonesia. Major IVD players are also collaborating with regional partners to expand their reach in developing countries across Asia Pacific.

The Chinese IVD market is growing rapidly, fueled by rising demand for molecular diagnostics, point-of-care testing, and digital health integration. Molecular diagnostics are particularly in demand for infectious diseases and oncology, supported by public health initiatives and increased healthcare spending.

Japan’s IVD market growth is driven by an aging population and progress in personalized medicine. Key trends include a growing use of molecular diagnostics for oncology and genetic testing, which aid in identifying targeted treatments for age-related diseases

Latin America In Vitro Diagnostics Market Trends:

The IVD market in Latin America is expanding due to increased healthcare investments, a focus on disease prevention, and enhanced healthcare access. A prominent trend is the adoption of point-of-care testing for infectious diseases like dengue, Zika, and COVID-19, especially in remote areas. Demand for molecular diagnostics in oncology is also growing as awareness of personalized medicine rises. Public-private partnerships and government initiatives are building diagnostics infrastructure, making advanced testing technologies more accessible across the region.

Middle East & Africa In Vitro Diagnostics Market Trends:

The IVD market in the Middle East and Africa (MEA) is set for growth, driven by increased healthcare spending and the prevalence of infectious diseases. Major trends include the adoption of advanced molecular diagnostics and point-of-care testing to improve disease detection and management. Additionally, a focus on personalized medicine and government initiatives aimed at enhancing healthcare infrastructure are supporting market expansion. Collaborations between local and international players are fostering innovation, making diagnostic solutions more accessible across the region.

Browse through Grand View Research's Category Clinical Diagnostics Industry Research Reports.

The global saliva collection and diagnostics market size was estimated at USD 818.9 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030.

The global cholesterol testing products and services market size was estimated at USD 19.85 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2030.

Key Companies & Market Share Insights:

Among the prominent players in the IVD market are F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, and Danaher. These companies actively pursue strategies like new product launches, mergers and acquisitions, and partnerships to strengthen and diversify their product offerings. These efforts are focused on expanding their product portfolios, introducing technologically advanced and innovative diagnostic tools, and improving their competitive positioning within the market.

Emerging companies in the IVD sector, including Llusern Scientific, Biocartis Group NV, ARUP Laboratories, Veracyte, and Exact Sciences Corp, are also making strides. These companies concentrate on developing novel and accurate IVD testing products, contributing to overall healthcare improvements. They frequently collaborate with research institutions, governmental bodies, and global leaders to expand their product reach and presence in new, high-potential markets.

Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

In Vitro Diagnostics (IVD) Market Growth Analysis & Forecast Research Report, 2030

The global in vitro diagnostics (IVD) market was valued at approximately USD 77.92 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2030. This growth can be attributed to several factors, including the increasing adoption of IVD technologies due to the rising prevalence of infectious and chronic diseases. The development and integration of automated IVD systems in laboratories and hospitals, which aim to deliver more efficient, accurate, and error-free diagnoses, are also expected to significantly drive market growth. Additionally, the continuous introduction of new IVD products by key industry players contributes to this positive trend. For instance, in November 2023, ARUP Laboratories obtained a CE mark under the EU-IVDR for the AAV5 DetectCDx, a companion diagnostic test that determines the eligibility of patients with severe hemophilia A for BioMarin's gene therapy, Roctavian.

Technological advancements in IVD systems, particularly improvements in accuracy, portability, and cost-effectiveness, are among the high-impact factors influencing this market. Innovations in highly accurate clinical laboratory tests are fostering global adoption of novel IVD diagnostics. For example, in June 2023, Japan's Ministry of Health, Labour, and Welfare granted marketing approval to Toray Industries, Inc. for its Toray APOA2-iTQ, a diagnostic tool used for pancreatic cancer detection. Similarly, in March 2023, Abbott received U.S. FDA clearance for its novel laboratory blood test for Traumatic Brain Injury (TBI). These developments highlight the increasing approval of IVD tests targeting life-threatening diseases, which is expected to create significant opportunities in untapped market segments.

Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics (IVD) Market

Leading companies in the IVD market are adopting diverse strategies to strengthen their positions, often introducing new products and forming partnerships to attract more customers and meet evolving diagnostic needs. For instance, in March 2023, BD received 510(k) clearance from the U.S. FDA for its BD Vaginal Panel on the BD COR System, aimed at detecting infectious causes of vaginitis. In August 2023, the Precision Medicine Centre (PMC) partnered with the Regional Molecular Diagnostic Service (RMDS) to implement genomic technology for cancer diagnosis in Northern Ireland. These strategic collaborations and product launches are critical for companies seeking to leverage cutting-edge technologies in diagnostics.

Product Segmentation Insights:

In terms of products, the reagents segment accounted for the largest market share, representing 65.88% of total revenue in 2023. This segment is expected to maintain its dominance, growing at the fastest CAGR from 2024 to 2030. The growth of the reagents segment is driven by extensive research and development (R&D) efforts by key players aimed at developing novel reagents and test kits. For example, in February 2023, BD received market approval for its BD Onclarity HPV Assay, which is used with the ThinPrep Pap Test in the U.S. Ongoing R&D efforts focused on faster cancer detection and precision medicine are prompting companies to concentrate on specialized, profitable areas of the IVD market. In March 2023, QIAGEN formed a partnership with Servier to develop a companion diagnostic test for TIBSOVO, which is indicated for the treatment of acute myeloid leukemia, a type of blood cancer.

The growing demand for precision medicine is expected to further boost the overall demand for these novel reagents and consumables. The instruments segment held the second-largest share of the IVD market in 2023. Increasing approvals of novel IVD instruments are likely to contribute to the segment's growth. For instance, in April 2023, bioMérieux SA submitted a 510(k) application to the U.S. FDA for VITEK REVEAL, a rapid antimicrobial susceptibility testing (AST) system. Moreover, companies are aligning their instrument launches to meet the increasing demand for genetic tests globally. In March 2022, Thermo Fisher Scientific introduced the Ion Torrent Genexus Dx Integrated Sequencer for both research and diagnostic purposes, showcasing the alignment of technological advancements with the growing needs of genetic testing.

In conclusion, the global IVD market is poised for substantial growth, driven by the increasing incidence of infectious and chronic diseases, rising demand for precision medicine, and ongoing advancements in diagnostic technologies. Companies are continuously innovating, launching new products, and forming strategic partnerships to meet the evolving needs of healthcare providers and patients, which will further accelerate market expansion.

Order a free sample PDF of the In Vitro Diagnostics (IVD) Market Intelligence Study, published by Grand View Research.